Results 71 to 80 of about 4,514,148 (169)

Contrast-Enhanced Mammography in the Diagnosis of Breast Angiosarcoma

Case Reports in Radiology, 2021
A 60-year-old female presented for further assessment of a new right breast lump (November 2020). She had a history of a stage I (T1bN0M0) right breast invasive mammary carcinoma, grade 2 (score 7/9) with receptors ER/PR-negative, HER2/neu-positive ...
Maya Grisaru Kacen, Nikhil Sangle, Anat Kornecki   +2 more
doaj   +1 more source

Design of an In Vivo‐Like Phantom for Quantitative Body CEST MRI

Magnetic Resonance in Medicine, Volume 97, Issue 1, Page 454-463, January 2027.
ABSTRACT Purpose To design and validate a reproducible in vivo‐like fat‐containing CEST phantom that enables robust quantitative CEST MRI for body applications by providing physiologically realistic relaxation properties, relevant endogenous CEST contrasts (amide, guanidino, rNOE, and semi‐solid MT), and a controlled fat component.
Petr Menshchikov, Petr Bulanov, Neele Kempa, Mark E. Ladd, Andreas Korzowski, Philip S. Boyd   +5 more
wiley   +1 more source

Bilateral Breast Gradient Insert Prototype for Strong Diffusion Encoding at 3 T

Magnetic Resonance in Medicine, Volume 97, Issue 1, Page 414-424, January 2027.
ABSTRACT Purpose Diffusion MRI has shown promise for breast cancer screening, lesion characterization, and treatment response monitoring without contrast agents, but further translation is constrained by the gradient performance of conventional systems.
Gerrit Cornelis Arends, Edwin Versteeg, Feng Jia, Dennis W. J. Klomp, Maxim Zaitsev, Sebastian Littin, Chantal M. W. Tax   +6 more
wiley   +1 more source

Basics of Contrast-Enhanced Spectral Mammography [PDF]

Contrast-Enhanced Spectral Mammography (CESM) is an advanced diagnostic technique that combines anatomical and functional breast imaging with the use of iodinated contrast to enhance potential malignant lesion visualization.
Lasher, Megan A
core  

Identification of a Circular RNA as a Potential Diagnostic and Prognostic Biomarker in Breast Cancer Through Integrated Bioinformatic and Experimental Analyses

Analytical Science Advances, Volume 7, Issue 2, December 2026.
Forty circular RNAs were found to be significantly dysregulated in microarray datasets. Expression levels of hsa_circ_0000231 were significantly upregulated in breast cancer (BC) tissues, while hsa_circ_0011385 exhibited no significant difference in expression levels. This study also revealed that hsa_circ_0000231/hsa‐miR‐5683/CCNB1 regulatory axis may
MohamadReza Hashemi, Pejman Morovat, Azin Khoshghiafeh, Novin Nikbakhsh, Mohamadreza Ahmadifard   +4 more
wiley   +1 more source

The Evolution of Breast Cancer Detection: A Review of Imaging, Machine Learning, and Multimodal Strategies

Computational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT Breast cancer is still a serious problem in the world arena, where its early and prompt detection is the most important factor in improving patient prognosis and survival. The use of traditional diagnostic techniques, such as imaging (e.g., mammography and ultrasound) and subsequent histopathological examination, is the mainstay, which ...
Likhon Chandra Sarkar, Farida Siddiqi Prity, Farhad Hussain, Anup Talukder, Mirza Raquib, Sharmina Rahman, MD Jiabul Hoque   +6 more
wiley   +1 more source

Big Data in Cancer Genomics: Computational Foundations and Emerging Pathways for Precision Oncology

Computational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT This review aims to explore the computational foundations of big data in cancer genomics and examine emerging pathways that support precision oncology and personalized cancer care. A narrative review approach was adopted to synthesize evidence from PubMed, Scopus, Web of Science, and IEEE Xplore.
Nur Vanu, Nur Mohammad, Fahad Ahmed, Towsif Alam, Koushik Saha, Durga Shahi, Adib Hossain, Mia Md. Tofayel Gonee Manik, Mst. Rina Parvin   +8 more
wiley   +1 more source

De‐Escalation of Neoadjuvant Treatment for HER2‐Positive Breast Cancer

International Journal of Cancer, Volume 159, Issue 10, Page 2393-2402, 15 November 2026.
ABSTRACT With improved prognosis in early HER2‐positive breast cancer, safely de‐escalating treatment is increasingly investigated to minimize overtreatment. This article focuses on neoadjuvant de‐escalation strategies for HER2‐positive breast cancer.
Yiyin Ma, Dedian Chen, Sheng Huang
wiley   +1 more source

Potential Association of BRCA Mutation and Lymphocytic Lobulitis

Clinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Lymphocytic lobulitis (LL) is a rare fibroinflammatory breast lesion historically associated with long‐standing Type 1 diabetes mellitus and autoimmune conditions. Recent evidence suggests possible links between LL and hereditary breast cancer syndromes, particularly BRCA mutations. We present the case of a BRCA1 mutation carrier who developed
Parul Garg, Sena Park, Femi E. Ayeni, Senarath Edirimanne   +3 more
wiley   +1 more source

Diagnostic value of qualitative and quantitative enhancement parameters on contrast-enhanced mammography

PURPOSE: To determine whether qualitative and quantitative enhancement parameters obtained from contrast-enhanced mammography (CEM) can be used in predicting malignancy.
Kul, Sibel, Selçuk Akkaya, Sibel Kul, Akkaya, Selçuk, Musa Kul, Kul, Musa   +5 more
core   +1 more source